Literature DB >> 22976727

Myositis ossificans traumatica of the masticatory muscles.

Hitoshi Nemoto1, Noriyoshi Sumiya, Yoshinori Ito, Naohiro Kimura, Ayako Akizuki, Naoki Maruyama.   

Abstract

Myositis ossificans traumatica (MOT) is a disease in which muscular ossification develops following trauma. Almost all cases of MOT are found in skeletal muscle. The authors report in a 39-year-old man MOT involving several muscles in the head and neck, namely, bilateral masseter muscles, the left temporal muscle, the left lateral pterygoid muscle, and the left frontal muscle. Involvement of the lateral pterygoid muscle is especially rare.

Entities:  

Mesh:

Year:  2012        PMID: 22976727     DOI: 10.1097/SCS.0b013e31825b33de

Source DB:  PubMed          Journal:  J Craniofac Surg        ISSN: 1049-2275            Impact factor:   1.046


  4 in total

1.  Post-infectious myositis ossificans in medial, lateral pterygoid muscles: A case report and review of the literature.

Authors:  Qian Jiang; Min-Jie Chen; Chi Yang; Ya-Ting Qiu; Zhen Tian; Zhi-Yuan Zhang; Wei-Liu Qiu
Journal:  Oncol Lett       Date:  2014-11-19       Impact factor: 2.967

2.  Myositis Ossificans Traumatica of the Temporal Muscle: a Case Report and Literature Review Emphasizing Radiographic Features on Computed Tomography and Magnetic Resonance Imaging.

Authors:  Erika Antonia Dos Anjos Ramos; Luciana Munhoz; Basílio Almeida Milani; Fernando Pando de Matos; Emiko Saito Arita
Journal:  J Oral Maxillofac Res       Date:  2019-12-30

3.  A rare isolated unilateral myositis ossificans traumatica of the lateral pterygoid muscle: a case report.

Authors:  Alessia Spinzia; Guido Moscato; Emanuele Broccardo; Lara Castelletti; Fabio Maglitto; Giovanni Dell'Aversana Orabona; Pasquale Piombino
Journal:  J Med Case Rep       Date:  2014-06-26

Review 4.  Myositis ossificans traumatica of the masticatory muscles: etiology, diagnosis and treatment.

Authors:  Marcel Hanisch; Lale Hanisch; Leopold F Fröhlich; Richard Werkmeister; Lauren Bohner; Johannes Kleinheinz
Journal:  Head Face Med       Date:  2018-10-29       Impact factor: 2.151

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.